Orange Book product · Generic (ANDA)
BACITRACIN ZINC AND POLYMYXIN B SULFATE
BACITRACIN ZINC; POLYMYXIN B SULFATE
At a glance
Feb 27, 2002
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 27, 2002
24 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
BACITRACIN ZINC; POLYMYXIN B SULFATE
Strength
500 UNITS/GM;10,000 UNITS/GM
Dosage form
OINTMENT
Route
OPHTHALMIC
TE code
Not listed
Application
ANDA 065022
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BACITRACIN ZINC; POLYMYXIN B SULFATE
- 1985POLYSPORINBrand (NDA)
NDA 050167 · GLAXOSMITHKLINE
- 1995BACITRACIN ZINC AND POLYMYXIN B SULFATEGeneric (ANDA)
ANDA 064028 · SCIEGEN PHARMS
- 1995BACITRACIN ZINC AND POLYMYXIN B SULFATEGeneric (ANDA)
ANDA 064046 · BAUSCH AND LOMB INC
- 1987BACITRACIN ZINC-POLYMYXIN B SULFATEGeneric (ANDA)
ANDA 062849 · NASKA
- 1983OCUMYCINGeneric (ANDA)
ANDA 062430 · PHARMAFAIR
- —POLYSPORINGeneric (ANDA)
ANDA 061229 · MONARCH PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
